Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCA versus continuous morphine infusion for vaso-occlusive crisis in sickle cell disease
NL-OMON26593Active, not recruiting
- Sponsor
- Academic Medical Center
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of morphine in sickle cell disease (SCD) (2 arms), sponsored by Academic Medical Center. Primary endpoints: Pain intensity, Morphine dosage and 1 more. Started Oct 2004; status: active, not recruiting.
02
Drugs
morphine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NL-OMON26593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26593.